|
- 2018
Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III gliomaDOI: 10.1080/2162402X.2017.1391972 Keywords: grade II glioma, grade III glioma, immunotherapy, peptide vaccine, IMA950, spontaneous T cell responses, astrocytoma, oligodendroglioma, ependymoma Abstract:
|